Grant: Master's Award: Canada Graduate Scholarships
University of British Columbia
$17,500.00
Neurovascular Unit for Studying Alzheimer's Disease
FY 2019-20
Summary
"Alzheimer's Disease is a neurodegenerative disease which affects everyone it touches. To date, animal models have been unsuccessful in replicating Alzheimer's disease based on the physiological difference between humans and animals [1]. This is why there is an abundance of research in the field of modelling Alzheimer's Disease using new methods. In order to mimic the native environment of Alzheimer's Disease, an initial environment of a healthy blood-brain barrier needs to be developed. We aim to develop a model using a microchannel that will be embedded with a needle and a surrounding liquid. Then, through UV curing of the liquid and removing the needle, we will form a hollow, lumen structure. The gel that we are using will be mixed with cells from the brain (astrocytes, pericytes, neurons) to form the ""brain"", and cells found within the lumen (endothelial cells, smooth muscle cells) will form the ""blood"". Together, we will form a model of the blood-brain barrier. We can validate this model through real-time imaging of the cell-cell interactions, since the structure will be made using a clear, oxygen-permeable material (polydimethylsiloxane). Additionally, we will be able to mimic the native flow environment by using syringe pumps to flow nutrients to the ""brain"" side and through the lumen to the ""blood side. Through step-by-step modelling of Alzheimer's Disease, we hope to identify therapeutic strategies that will help in the clinical advancement of accessible, therapeutic drugs. References [1] F. Q. Zhou et al., ""Lack of human-like extracellular sortilin neuropathology in transgenic Alzheimer's disease model mice and macaques,"" Alzheimer's Res. Ther., vol. 10, no. 1, pp. 1–15, 2018. "
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
428742
Name
Cameron Tiffany C
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Neurovascular Unit for Studying Alzheimer's Disease
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
3d Model; Alzheimer'S Disease; Blood-Brain Barrier; Dementia; Microfabrication; Microfluidics; Neurodegenerative; Neurovascular; Organ-On-A-Chip; Tissue Engineering
Abstract
"Alzheimer's Disease is a neurodegenerative disease which affects everyone it touches. To date, animal models have been unsuccessful in replicating Alzheimer's disease based on the physiological difference between humans and animals [1]. This is why there is an abundance of research in the field of modelling Alzheimer's Disease using new methods. In order to mimic the native environment of Alzheimer's Disease, an initial environment of a healthy blood-brain barrier needs to be developed. We aim to develop a model using a microchannel that will be embedded with a needle and a surrounding liquid. Then, through UV curing of the liquid and removing the needle, we will form a hollow, lumen structure. The gel that we are using will be mixed with cells from the brain (astrocytes, pericytes, neurons) to form the ""brain"", and cells found within the lumen (endothelial cells, smooth muscle cells) will form the ""blood"". Together, we will form a model of the blood-brain barrier. We can validate this model through real-time imaging of the cell-cell interactions, since the structure will be made using a clear, oxygen-permeable material (polydimethylsiloxane). Additionally, we will be able to mimic the native flow environment by using syringe pumps to flow nutrients to the ""brain"" side and through the lumen to the ""blood side. Through step-by-step modelling of Alzheimer's Disease, we hope to identify therapeutic strategies that will help in the clinical advancement of accessible, therapeutic drugs. References [1] F. Q. Zhou et al., ""Lack of human-like extracellular sortilin neuropathology in transgenic Alzheimer's disease model mice and macaques,"" Alzheimer's Res. Ther., vol. 10, no. 1, pp. 1–15, 2018. "
Competitiondate
201912
Approvedterm2
1 yr 0 mth
Pinamesdelim
Cameron, Tiffany C
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~